Event

GSK plc (GLAXF)

GSK plc (GLAXF) Files Form 6-K

Business News

Forte Biosciences Inc. (FBRX)

Forte Biosciences Inc - Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

SEC News

Abeona Therapeutics Inc. (ABEO)

📋 Silverstein Christine Berni (Director) plans to sell 20K shares of ABEONA THERAPEUTICS INC. (at $5.09 each, total $102K) Filed: …


Company Report

MAIA Biotechnology Inc. (MAIA)

Understanding Clinical Trials - Part 1 of 2

FDA Approval

FDA approves LAMOTRIGINE from TORRENT

Final approval of ANDA #ANDA #217100 for LAMOTRIGINE. Decision date: 01/08/2026

About Us

The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.

Our strategies:

  • a combination of various open sources of information with the identification and use of those that provide information most quickly;
  • extracting information mainly by automatic means using artificial intelligence;
  • providing users with structured information with modern available development tools;
  • the use of approaches and tools of machine learning methods to identify the most important events that affect the market;